GlobeNewswire
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities. The below transactions concern allocation of share options. For further details, reference is made to Coloplast’s Remuneration Policy which was adopted in 2020. The policy is available on the group website at this address:https://www.coloplast.com/management-remuneration/ 1Details of the person discharging managerial responsibilities/person closely associateda)NameKristian Villumsen2Reason for the notificationa)Position/statusPresident & CEOb)Initial notification/AmendmentInitial notification3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitora)NameColoplast A/S (CVR-no.: 69749917)b)LEI529900NN7SOJ5QG82X674Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Share options relating to B shares Identification codeISIN: DK0060448595 (B shares)b)Nature of the transactionShare option allocationc)Price and volumePriceVolume0.0061,041d)Aggregated information - Aggregated volume61,041 share options- PriceDKK 0.00e)Date of the transaction2021-01-22, 12:00 UTCf)Place of the transactionOutside a trading venue 1Details of the person discharging managerial responsibilities/person closely associateda)NameAnders Lonning-Skovgaard2Reason for the notificationa)Position/statusExecutive Vice President & CFOb)Initial notification/AmendmentInitial notification3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitora)NameColoplast A/S (CVR-no.: 69749917)b)LEI529900NN7SOJ5QG82X674Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Share options relating to B shares Identification codeISIN: DK0060448595 (B shares)b)Nature of the transactionShare option allocationc)Price and volumePriceVolume0.0030,184d)Aggregated information - Aggregated volume30,184 share options- PriceDKK 0.00e)Date of the transaction2021-01-22, 12:00 UTCf)Place of the transactionOutside a trading venue 1Details of the person discharging managerial responsibilities/person closely associateda)NamePaul Marcun2Reason for the notificationa)Position/statusExecutive Vice President, Growthb)Initial notification/AmendmentInitial notification3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitora)NameColoplast A/S (CVR-no.: 69749917)b)LEI529900NN7SOJ5QG82X674Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Share options relating to B shares Identification codeISIN: DK0060448595 (B shares)b)Nature of the transactionShare option allocationc)Price and volumePriceVolume0.0030,933d)Aggregated information - Aggregated volume30,933 share options- PriceDKK 0.00e)Date of the transaction2021-01-22, 12:00 UTCf)Place of the transactionOutside a trading venue 1Details of the person discharging managerial responsibilities/person closely associateda)NameAllan Rasmussen2Reason for the notificationa)Position/statusExecutive Vice President, Global Operationsb)Initial notification/AmendmentInitial notification3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitora)NameColoplast A/S (CVR-no.: 69749917)b)LEI529900NN7SOJ5QG82X674Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Share options relating to B shares Identification codeISIN: DK0060448595 (B shares)b)Nature of the transactionShare option allocationc)Price and volumePriceVolume0.0027,107d)Aggregated information - Aggregated volume27,107 share options- PriceDKK 0.00e)Date of the transaction2021-01-22, 12:00 UTCf)Place of the transactionOutside a trading venue 1Details of the person discharging managerial responsibilities/person closely associateda)NameNicolai Buhl Andersen2Reason for the notificationa)Position/statusExecutive Vice President, Innovationb)Initial notification/AmendmentInitial notification3Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitora)NameColoplast A/S (CVR-no.: 69749917)b)LEI529900NN7SOJ5QG82X674Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Share options relating to B shares Identification codeISIN: DK0060448595 (B shares)b)Nature of the transactionShare option allocationc)Price and volumePriceVolume0.0015,643d)Aggregated information - Aggregated volume15,643 share options- PriceDKK 0.00e)Date of the transaction2021-01-22, 12:00 UTCf)Place of the transactionOutside a trading venue This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Hannah Katrine Larsen, tel.: +45 4911 3616. For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. +45 4911 1111 Ellen BjurgertVice President, Investor RelationsTel. +45 4911 1800 /+45 4911 3376Email: dkebj@coloplast.com Press and mediaDennis Kaysen Director, Corporate CommunicationTel. +45 4911 2608Email: dkdk@coloplast.com AddressColoplast A/SHoltedam 1DK-3050 HumlebaekDenmarkCompany reg. (CVR) no. 69749917 Websitewww.coloplast.com This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail. Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees. The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-01.All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark. Attachment 22012021 allocation of share options